Financial News Feed

Weaker Buy Today ACHN ranks #565 as BUY CANDIDATE. Stronger Buy
Today ACHN ranks #565 as BUY CANDIDATE.

ACHN stock Achillion Pharmaceuticals

ACHN stock
Achillion Pharmaceuticals

The stock of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is a huge mover today! The stock increased 2.56% or $0.08 during the last trading session, reaching Bilibili Inc - American Depositary Shares...

Read more

Investors sentiment decreased to 0.9 in 2018 Q4. Its down 0.42, from 1.32 in 2018Q3. It fall, as 17 investors sold Achillion Pharmaceuticals, Inc. shares while...

Read more

Private Capital Advisors Inc increased Stryker Corp (SYK) stake by 42.66% reported in 2018Q4 SEC filing. Private Capital Advisors Inc acquired 12,475 shares as Achillion Pharmaceuticals Inc (NASDAQ:AC...

Read more

Since Scholar Rock Holding Corporation (NASDAQ:SRRK) and Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) are part of the Biotechnology industry, they are...

Read more

Wienerberger AG (WBAG:WIE) currently has a Value Composite score of 15. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite...

Read more

Since Sutro Biopharma Inc. (NASDAQ:STRO) and Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect th...

Read more

Checking up on some indicators, we can see that Achillion Pharmaceut (ACHN)’s last month opinion signal is 40% Buy. This is the combined signal for the previous month when applying a wide array of s...

Read more

As Biotechnology businesses, Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) and Cytokinetics Incorporated (NASDAQ:CYTK), are affected by compare. This especially applies to their analyst recommendations...

Read more

Analysts forecast that Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) will report ($0.13) earnings per share for the current quarter, Zacks reports. Zero analysts have made estimates for Achillion Phar...

Read more

Analysts expect SecureWorks Corp. (NASDAQ:SCWX) to report $-0.04 EPS on March, 27.They anticipate $0.11 EPS change or 73.33% from last quarter's $-0.15 EPS. Sentiment for Achillion Pharmaceuticals Inc...

Read more

We will be contrasting the differences between ImmuCell Corporation (NASDAQ:ICCC) and Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) as far as dividends, institutional ownership, analyst recommendations...

Read more

This is therefore a comparing of the institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation in Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) and Codexi...

Read more

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) making news as their share price hit $3.01 at the end of the most recent trading day. Considering that price volatility is equivalent to risk, a commodity...

Read more

Based on the latest filings with the SEC, investors are looking at Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)’s short data and trying to figure out market sentiment on which way the market thinks...

Read more

Walnut Private Equity Partners Llc decreased its stake in Targa Resources Corp (TRGP) by 36.72% based on its latest 2018Q4 regulatory filing with the SEC. Mak Capital One Llc increased its stake in Ac...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank